Jin-shui Huan-xian Granule in the Treatment of IPF

• Status: Recruiting
• Trial end date: 2022-09-30
• Target enrollment: 0
• Participant gender: All

Summary

This study is to evaluate the efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis (IPF), establish the treatment scheme, and obtain the high quality clinical evidences.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Henan University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

• A confirmed diagnosis stable IPF.

• Age ranges from 40 years to 85 years.

• TCM Syndrome differentiation meets criteria of pattern of Lung Qi deficiency, yin deficiency and inter heat, and lung-kidney qi deficiency.

• Without participanting in any other trial.

• With signed informed consent.

Exclusion Criteria:

• Pregnant, nursing or may become pregnant women.

• Patients with unconscious, dementia or mental disorders.

• Patients with severe cardiac dysfunction.

• Patients with severe liver and kidney diseases.

• Patients with asthma, bronchiectasis, active pulmonary tuberculosis, pulmonary embolism, chronic obstructive pulmonary disease, chronic respiratory failure or other severe respiratory diseases.

• Patients with tumor after resection, radiotherapy or chemotherapy in the past 5 years.

• Patients with severe neuromuscular disorders, severe arthritis or severe peripheral vascular diseases.

• Patients with long-term bedridden.

• Patients who are allergic to any of the treatment drugs.